This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Evive Biotechnology (Shanghai) Ltd, University of Pittsburgh. Active years: 2022.
Company Filing History:
1 out of 5 
1 out of 1,959 
Years Active: 2022
Title: The Innovative Contributions of Misty Lynn Good
Introduction
Misty Lynn Good is a notable inventor based in St. Louis, MO. She has made significant contributions to the field of medical research, particularly in the treatment of intestinal diseases. Her work has the potential to impact the lives of many patients suffering from serious health conditions.
Latest Patents
Misty Lynn Good holds a patent for the invention titled "Use of IL-22 in treating necrotizing enterocolitis." This invention relates to methods of preventing and/or treating necrotizing enterocolitis or other intestinal inflammations using IL-22, a dimer or a multimer thereof. This innovative approach could provide new avenues for treatment in the medical community.
Career Highlights
Throughout her career, Misty has worked with various organizations that have contributed to her expertise. She has been associated with Evive Biotechnology, a company based in Shanghai, and the University of Pittsburgh. These experiences have enriched her knowledge and skills in the field of biotechnology and medical research.
Collaborations
Misty has collaborated with esteemed colleagues such as Jay Kennedy Kolls and Xiaoqiang Yan. These partnerships have likely fostered a productive environment for innovation and research.
Conclusion
Misty Lynn Good's contributions to medical research and her innovative patent demonstrate her commitment to improving healthcare solutions. Her work continues to inspire future advancements in the treatment of intestinal diseases.